Market Overview

UPDATE: Sterne Agee Reiterates Neutral Rating, Raises PT on ICON plc

Related ICLR
Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Lowest PEG Ratio
ICON Is Now A Strong Buy: Should It Be In Your Portfolio?

In a report published Monday, Sterne Agee Group reiterated its Neutral rating on ICON plc (NASDAQ: ICLR), and slightly raised its price target from $24.00 to $25.00.

Sterne Agee noted, “Not unlike our caution on PRXL, we must question ICLR's ability to provide accurate forecasts. However, ICLR's forecasting and cost management skills have proven quite conservative over the years. ICLR is projecting EBIT margins to return to levels achieved a few years back, while PRXL is projecting 2-3 year margins never achieved by the company. We use a 15x multiple on our CY14 EPS estimate to arrive at a $25 price target, which compares to an average 17x over the past 10 years.”

ICON plc closed on Friday at $28.29.

Latest Ratings for ICLR

DateFirmActionFromTo
Oct 2014ISI GroupDowngradesStrong BuyNeutral
Aug 2014Credit SuisseMaintainsOutperform
Jul 2014BarclaysMaintainsOverweight

View More Analyst Ratings for ICLR
View the Latest Analyst Ratings

Posted-In: Sterne Agee GroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (ICLR)

Around the Web, We're Loving...

Get Benzinga's Newsletters